Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Muscular Dystrophy, Facioscapulohumeral

• Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1
• Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
• A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
• Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
• Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
• Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension
• Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
• Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
• Study of Testosterone and rHGH in FSHD
• Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
• Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
• Study Evaluating MYO-029 in Adult Muscular Dystrophy
• Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
• Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy